886230-74-6

Basic information

• Product Name: 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
• Synonyms: 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;3-iodo-6-nitro-1-(tetrahydropyran-2-yl) -1H-indazole
• CAS NO: 886230-74-6
• Molecular Formula: C₁₂H₁₂IN₃O₃
• Molecular Weight: 373.14645
• Product Categories: axitinib intermediate;Intermediate of Axitinib
• Mol File: 886230-74-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 504.111 °C at 760 mmHg
• Flash Point: 258.678 °C
• Appearance: /
• Density: 2.01
• Storage Temp.: 2-8°C
• PKA: -2.96±0.50(Predicted)
• CAS DataBase Reference: 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(886230-74-6)
• EPA Substance Registry System: 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(886230-74-6)

Safety Data

• Hazardous Substances Data: 886230-74-6(Hazardous Substances Data)

Usage

Uses

3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole is used as a reactant in the preparation of carbazole derivatives as kinase inhibitors.

Upstream product

• 150187-67-0 6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole 
• 110-87-2 3,4-dihydro-2H-pyran 
• 99-55-8 2-methyl-5-nitroaniline 
• 7597-18-4 6-nitroindazole 
• 70315-70-7 3-iodo-6-nitro-1H-indazole 

Downstream Products

• 886230-76-8 (Ε)-6-amino-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)indazole 
• 1012060-43-3 methyl 6-(2-(1-(tetrahydro-2H-pyran-2-yl)-3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamido)hexanoate 
• 1012060-44-4 methyl 6-(2-(3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamido)hexanoate 
• 1012056-56-2 N-(5-(hydroxycarbamoyl)pentyl)-2-(3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide 
• 1133966-04-7 (E)-methyl 5-(2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)phenoxy)pentanoate 
• 1133966-05-8 (E)-methyl 5-(2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)phenoxy)pentanoate 
• 1133966-14-9 (E)-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzenamine 
• 1133966-15-0 (E)-methyl 5-(2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)phenylamino)pentanoate 
• 1133966-18-3 (E)-ethyl 6-oxo-6-(2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)phenylamino)hexanoate 
• 1133966-19-4 (E)-ethyl 6-oxo-6-(2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)phenylamino)hexanoate 
• 1133966-20-7 (E)-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzenamine 
• 1133966-21-8 (E)-methyl 7-oxo-7-(2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)phenylamino)heptanoate 
• 885126-35-2 (E)-N-methyl-2-{[3-(2-(pyridin-2-yl)ethenyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio}benzamide 
• 319460-85-0 axitinib 

Relevant articles and documents

2,3-dimethyl-6-urea -2H-indazoles and its preparation method and application

The invention discloses a 2, 3-dimethyl-6-urea-2H-indazole compound shown by the following general formula (I), medicinal salt or a solvent compound thereof, wherein Ar is substituted or unsubstituted phenyl or aromatic matrix. The invention also discloses a preparation method and application of the compound. The compound can regulate signal transduction of tyrosine kinase, inhibit bad cellular proliferation, and particularly has obvious curative effect for tumors.

VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY

The present invention relates to VEGFR inhibitors and their use in the treatment of cell proliferative diseases such as cancer. The said derivatives may further act as HDAC inhibitors.

METHODS FOR PREPARING INDAZOLE COMPOUNDS

The invention relates to methods for preparing compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof. Compounds of the formula (I) are useful as anti-angiogenesis agents and as agents for modulating and/or inhibiting the activity of protein kinases, thus providing treatments for cancer or other diseases associated with cellular proliferation mediated by protein kinases.